Aarti Drugs Balans Gezondheid
Financiële gezondheid criteriumcontroles 5/6
Aarti Drugs heeft een totaal eigen vermogen van ₹12.8B en een totale schuld van ₹5.9B, wat de schuld-eigenvermogensverhouding op 46% brengt. De totale activa en totale passiva bedragen respectievelijk ₹24.3B en ₹11.5B. De EBIT Aarti Drugs is ₹2.4B waardoor de rentedekking 7.4 is. Het heeft contanten en kortetermijnbeleggingen van ₹295.6M.
Belangrijke informatie
46.0%
Verhouding schuld/eigen vermogen
₹5.88b
Schuld
| Rente dekkingsratio | 7.4x |
| Contant | ₹295.60m |
| Aandelen | ₹12.78b |
| Totaal verplichtingen | ₹11.52b |
| Totaal activa | ₹24.30b |
Recente financiële gezondheidsupdates
Aarti Drugs (NSE:AARTIDRUGS) Has A Somewhat Strained Balance Sheet
Sep 05
Is Aarti Drugs (NSE:AARTIDRUGS) A Risky Investment?
May 04These 4 Measures Indicate That Aarti Drugs (NSE:AARTIDRUGS) Is Using Debt Reasonably Well
Nov 22Does Aarti Drugs (NSE:AARTIDRUGS) Have A Healthy Balance Sheet?
Mar 17Aarti Drugs (NSE:AARTIDRUGS) Seems To Use Debt Quite Sensibly
Dec 08Recent updates
We Discuss Why Aarti Drugs Limited's (NSE:AARTIDRUGS) CEO Will Find It Hard To Get A Pay Rise From Shareholders This Year
Sep 20Aarti Drugs (NSE:AARTIDRUGS) Has A Somewhat Strained Balance Sheet
Sep 05Is Aarti Drugs (NSE:AARTIDRUGS) A Risky Investment?
May 04Aarti Drugs Limited Recorded A 9.0% Miss On Revenue: Analysts Are Revisiting Their Models
Feb 01Aarti Drugs (NSE:AARTIDRUGS) Is Due To Pay A Dividend Of ₹1.00
Jan 30Aarti Drugs' (NSE:AARTIDRUGS) Anemic Earnings Might Be Worse Than You Think
May 17These 4 Measures Indicate That Aarti Drugs (NSE:AARTIDRUGS) Is Using Debt Reasonably Well
Nov 22We Take A Look At Why Aarti Drugs Limited's (NSE:AARTIDRUGS) CEO Has Earned Their Pay Packet
Aug 28Here's Why We Think Aarti Drugs (NSE:AARTIDRUGS) Is Well Worth Watching
Aug 19Is Aarti Drugs Limited (NSE:AARTIDRUGS) Expensive For A Reason? A Look At Its Intrinsic Value
May 17Here's Why I Think Aarti Drugs (NSE:AARTIDRUGS) Is An Interesting Stock
Apr 04Does Aarti Drugs (NSE:AARTIDRUGS) Have A Healthy Balance Sheet?
Mar 17Aarti Drugs Limited's (NSE:AARTIDRUGS) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Mar 02What Percentage Of Aarti Drugs Limited (NSE:AARTIDRUGS) Shares Do Insiders Own?
Feb 17Why Aarti Drugs Limited (NSE:AARTIDRUGS) Should Be In Your Dividend Portfolio
Feb 04
What Can We Learn About Aarti Drugs' (NSE:AARTIDRUGS) CEO Compensation?
Jan 22Aarti Drugs' (NSE:AARTIDRUGS) Wonderful 432% Share Price Increase Shows How Capitalism Can Build Wealth
Jan 07If You Like EPS Growth Then Check Out Aarti Drugs (NSE:AARTIDRUGS) Before It's Too Late
Dec 23Aarti Drugs (NSE:AARTIDRUGS) Seems To Use Debt Quite Sensibly
Dec 08Aarti Drugs Limited's (NSE:AARTIDRUGS) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Nov 23How Much Of Aarti Drugs Limited (NSE:AARTIDRUGS) Do Insiders Own?
Nov 08Here's What We Learned About The CEO Pay At Aarti Drugs Limited (NSE:AARTIDRUGS)
Oct 11Analyse van de financiële positie
Kortlopende schulden: De korte termijn activa ( ₹12.6B ) AARTIDRUGS } overtreffen de korte termijn passiva ( ₹7.8B ).
Langlopende schulden: De kortetermijnactiva AARTIDRUGS ( ₹12.6B ) overtreffen de langetermijnschulden ( ₹3.7B ).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: De netto schuld/eigen vermogen ratio ( 43.7% ) AARTIDRUGS wordt als hoog beschouwd.
Schuld verminderen: De schuld/eigen vermogen-ratio van AARTIDRUGS is de afgelopen 5 jaar gedaald van 77% naar 46%.
Schuldendekking: De schuld van AARTIDRUGS wordt goed gedekt door de operationele kasstroom ( 52.4% ).
Rentedekking: De rentebetalingen op de schuld van AARTIDRUGS worden goed gedekt door EBIT ( 7.4 x dekking).